Medical Care
Global Pediatric Drug Development Services Market Research Report 2024
- Mar 11, 25
- ID: 3613
- Pages: 85
- Figures: 86
- Views: 1
The global market for Pediatric Drug Development Services was valued at US$ 1217 million in the year 2023 and is projected to reach a revised size of US$ 1754 million by 2030, growing at a CAGR of 5.6% during the forecast period.
Pediatric drug development services refer to professional services for drug research and development tailored to the needs of pediatric patients. These services include drug safety assessment, pharmacodynamics studies, clinical trial design, and other aspects. Pediatric Drug Development Services aim to ensure the safety and efficacy of drugs in pediatric patients, providing more appropriate treatment options for children. This service is of great significance in the field of pediatrics, contributing to improved child health and quality of life.
North American market for Pediatric Drug Development Services is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Pediatric Drug Development Services is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Pediatric Drug Development Services in Pharmaceutical Companies is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Pediatric Drug Development Services include IQVIA, Lonza, Fortrea, Certara, NGT BioPharma, PCI, Allucent, CTI, Sun-Novo, ICON, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Pediatric Drug Development Services, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pediatric Drug Development Services.
The Pediatric Drug Development Services market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pediatric Drug Development Services market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pediatric Drug Development Services companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
IQVIA
Lonza
Fortrea
Certara
NGT BioPharma
PCI
Allucent
CTI
Sun-Novo
ICON
Lewwin Pharma
Segment by Type
Preclinical Services
Clinical Services
Segment by Application
Pharmaceutical Companies
Medical Device Companies
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pediatric Drug Development Services company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Pediatric drug development services refer to professional services for drug research and development tailored to the needs of pediatric patients. These services include drug safety assessment, pharmacodynamics studies, clinical trial design, and other aspects. Pediatric Drug Development Services aim to ensure the safety and efficacy of drugs in pediatric patients, providing more appropriate treatment options for children. This service is of great significance in the field of pediatrics, contributing to improved child health and quality of life.
North American market for Pediatric Drug Development Services is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Pediatric Drug Development Services is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Pediatric Drug Development Services in Pharmaceutical Companies is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Pediatric Drug Development Services include IQVIA, Lonza, Fortrea, Certara, NGT BioPharma, PCI, Allucent, CTI, Sun-Novo, ICON, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Pediatric Drug Development Services, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pediatric Drug Development Services.
The Pediatric Drug Development Services market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pediatric Drug Development Services market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pediatric Drug Development Services companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
IQVIA
Lonza
Fortrea
Certara
NGT BioPharma
PCI
Allucent
CTI
Sun-Novo
ICON
Lewwin Pharma
Segment by Type
Preclinical Services
Clinical Services
Segment by Application
Pharmaceutical Companies
Medical Device Companies
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pediatric Drug Development Services company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pediatric Drug Development Services Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Preclinical Services
1.2.3 Clinical Services
1.3 Market by Application
1.3.1 Global Pediatric Drug Development Services Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Pharmaceutical Companies
1.3.3 Medical Device Companies
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Pediatric Drug Development Services Market Perspective (2019-2030)
2.2 Global Pediatric Drug Development Services Growth Trends by Region
2.2.1 Global Pediatric Drug Development Services Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Pediatric Drug Development Services Historic Market Size by Region (2019-2024)
2.2.3 Pediatric Drug Development Services Forecasted Market Size by Region (2025-2030)
2.3 Pediatric Drug Development Services Market Dynamics
2.3.1 Pediatric Drug Development Services Industry Trends
2.3.2 Pediatric Drug Development Services Market Drivers
2.3.3 Pediatric Drug Development Services Market Challenges
2.3.4 Pediatric Drug Development Services Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pediatric Drug Development Services Players by Revenue
3.1.1 Global Top Pediatric Drug Development Services Players by Revenue (2019-2024)
3.1.2 Global Pediatric Drug Development Services Revenue Market Share by Players (2019-2024)
3.2 Global Pediatric Drug Development Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Pediatric Drug Development Services Revenue
3.4 Global Pediatric Drug Development Services Market Concentration Ratio
3.4.1 Global Pediatric Drug Development Services Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pediatric Drug Development Services Revenue in 2023
3.5 Global Key Players of Pediatric Drug Development Services Head office and Area Served
3.6 Global Key Players of Pediatric Drug Development Services, Product and Application
3.7 Global Key Players of Pediatric Drug Development Services, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Pediatric Drug Development Services Breakdown Data by Type
4.1 Global Pediatric Drug Development Services Historic Market Size by Type (2019-2024)
4.2 Global Pediatric Drug Development Services Forecasted Market Size by Type (2025-2030)
5 Pediatric Drug Development Services Breakdown Data by Application
5.1 Global Pediatric Drug Development Services Historic Market Size by Application (2019-2024)
5.2 Global Pediatric Drug Development Services Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Pediatric Drug Development Services Market Size (2019-2030)
6.2 North America Pediatric Drug Development Services Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Pediatric Drug Development Services Market Size by Country (2019-2024)
6.4 North America Pediatric Drug Development Services Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Pediatric Drug Development Services Market Size (2019-2030)
7.2 Europe Pediatric Drug Development Services Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Pediatric Drug Development Services Market Size by Country (2019-2024)
7.4 Europe Pediatric Drug Development Services Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Pediatric Drug Development Services Market Size (2019-2030)
8.2 Asia-Pacific Pediatric Drug Development Services Market Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Pediatric Drug Development Services Market Size by Region (2019-2024)
8.4 Asia-Pacific Pediatric Drug Development Services Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Pediatric Drug Development Services Market Size (2019-2030)
9.2 Latin America Pediatric Drug Development Services Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Pediatric Drug Development Services Market Size by Country (2019-2024)
9.4 Latin America Pediatric Drug Development Services Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pediatric Drug Development Services Market Size (2019-2030)
10.2 Middle East & Africa Pediatric Drug Development Services Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Pediatric Drug Development Services Market Size by Country (2019-2024)
10.4 Middle East & Africa Pediatric Drug Development Services Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 IQVIA
11.1.1 IQVIA Company Details
11.1.2 IQVIA Business Overview
11.1.3 IQVIA Pediatric Drug Development Services Introduction
11.1.4 IQVIA Revenue in Pediatric Drug Development Services Business (2019-2024)
11.1.5 IQVIA Recent Development
11.2 Lonza
11.2.1 Lonza Company Details
11.2.2 Lonza Business Overview
11.2.3 Lonza Pediatric Drug Development Services Introduction
11.2.4 Lonza Revenue in Pediatric Drug Development Services Business (2019-2024)
11.2.5 Lonza Recent Development
11.3 Fortrea
11.3.1 Fortrea Company Details
11.3.2 Fortrea Business Overview
11.3.3 Fortrea Pediatric Drug Development Services Introduction
11.3.4 Fortrea Revenue in Pediatric Drug Development Services Business (2019-2024)
11.3.5 Fortrea Recent Development
11.4 Certara
11.4.1 Certara Company Details
11.4.2 Certara Business Overview
11.4.3 Certara Pediatric Drug Development Services Introduction
11.4.4 Certara Revenue in Pediatric Drug Development Services Business (2019-2024)
11.4.5 Certara Recent Development
11.5 NGT BioPharma
11.5.1 NGT BioPharma Company Details
11.5.2 NGT BioPharma Business Overview
11.5.3 NGT BioPharma Pediatric Drug Development Services Introduction
11.5.4 NGT BioPharma Revenue in Pediatric Drug Development Services Business (2019-2024)
11.5.5 NGT BioPharma Recent Development
11.6 PCI
11.6.1 PCI Company Details
11.6.2 PCI Business Overview
11.6.3 PCI Pediatric Drug Development Services Introduction
11.6.4 PCI Revenue in Pediatric Drug Development Services Business (2019-2024)
11.6.5 PCI Recent Development
11.7 Allucent
11.7.1 Allucent Company Details
11.7.2 Allucent Business Overview
11.7.3 Allucent Pediatric Drug Development Services Introduction
11.7.4 Allucent Revenue in Pediatric Drug Development Services Business (2019-2024)
11.7.5 Allucent Recent Development
11.8 CTI
11.8.1 CTI Company Details
11.8.2 CTI Business Overview
11.8.3 CTI Pediatric Drug Development Services Introduction
11.8.4 CTI Revenue in Pediatric Drug Development Services Business (2019-2024)
11.8.5 CTI Recent Development
11.9 Sun-Novo
11.9.1 Sun-Novo Company Details
11.9.2 Sun-Novo Business Overview
11.9.3 Sun-Novo Pediatric Drug Development Services Introduction
11.9.4 Sun-Novo Revenue in Pediatric Drug Development Services Business (2019-2024)
11.9.5 Sun-Novo Recent Development
11.10 ICON
11.10.1 ICON Company Details
11.10.2 ICON Business Overview
11.10.3 ICON Pediatric Drug Development Services Introduction
11.10.4 ICON Revenue in Pediatric Drug Development Services Business (2019-2024)
11.10.5 ICON Recent Development
11.11 Lewwin Pharma
11.11.1 Lewwin Pharma Company Details
11.11.2 Lewwin Pharma Business Overview
11.11.3 Lewwin Pharma Pediatric Drug Development Services Introduction
11.11.4 Lewwin Pharma Revenue in Pediatric Drug Development Services Business (2019-2024)
11.11.5 Lewwin Pharma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pediatric Drug Development Services Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Preclinical Services
1.2.3 Clinical Services
1.3 Market by Application
1.3.1 Global Pediatric Drug Development Services Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Pharmaceutical Companies
1.3.3 Medical Device Companies
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Pediatric Drug Development Services Market Perspective (2019-2030)
2.2 Global Pediatric Drug Development Services Growth Trends by Region
2.2.1 Global Pediatric Drug Development Services Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Pediatric Drug Development Services Historic Market Size by Region (2019-2024)
2.2.3 Pediatric Drug Development Services Forecasted Market Size by Region (2025-2030)
2.3 Pediatric Drug Development Services Market Dynamics
2.3.1 Pediatric Drug Development Services Industry Trends
2.3.2 Pediatric Drug Development Services Market Drivers
2.3.3 Pediatric Drug Development Services Market Challenges
2.3.4 Pediatric Drug Development Services Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pediatric Drug Development Services Players by Revenue
3.1.1 Global Top Pediatric Drug Development Services Players by Revenue (2019-2024)
3.1.2 Global Pediatric Drug Development Services Revenue Market Share by Players (2019-2024)
3.2 Global Pediatric Drug Development Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Pediatric Drug Development Services Revenue
3.4 Global Pediatric Drug Development Services Market Concentration Ratio
3.4.1 Global Pediatric Drug Development Services Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pediatric Drug Development Services Revenue in 2023
3.5 Global Key Players of Pediatric Drug Development Services Head office and Area Served
3.6 Global Key Players of Pediatric Drug Development Services, Product and Application
3.7 Global Key Players of Pediatric Drug Development Services, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Pediatric Drug Development Services Breakdown Data by Type
4.1 Global Pediatric Drug Development Services Historic Market Size by Type (2019-2024)
4.2 Global Pediatric Drug Development Services Forecasted Market Size by Type (2025-2030)
5 Pediatric Drug Development Services Breakdown Data by Application
5.1 Global Pediatric Drug Development Services Historic Market Size by Application (2019-2024)
5.2 Global Pediatric Drug Development Services Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Pediatric Drug Development Services Market Size (2019-2030)
6.2 North America Pediatric Drug Development Services Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Pediatric Drug Development Services Market Size by Country (2019-2024)
6.4 North America Pediatric Drug Development Services Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Pediatric Drug Development Services Market Size (2019-2030)
7.2 Europe Pediatric Drug Development Services Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Pediatric Drug Development Services Market Size by Country (2019-2024)
7.4 Europe Pediatric Drug Development Services Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Pediatric Drug Development Services Market Size (2019-2030)
8.2 Asia-Pacific Pediatric Drug Development Services Market Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Pediatric Drug Development Services Market Size by Region (2019-2024)
8.4 Asia-Pacific Pediatric Drug Development Services Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Pediatric Drug Development Services Market Size (2019-2030)
9.2 Latin America Pediatric Drug Development Services Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Pediatric Drug Development Services Market Size by Country (2019-2024)
9.4 Latin America Pediatric Drug Development Services Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pediatric Drug Development Services Market Size (2019-2030)
10.2 Middle East & Africa Pediatric Drug Development Services Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Pediatric Drug Development Services Market Size by Country (2019-2024)
10.4 Middle East & Africa Pediatric Drug Development Services Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 IQVIA
11.1.1 IQVIA Company Details
11.1.2 IQVIA Business Overview
11.1.3 IQVIA Pediatric Drug Development Services Introduction
11.1.4 IQVIA Revenue in Pediatric Drug Development Services Business (2019-2024)
11.1.5 IQVIA Recent Development
11.2 Lonza
11.2.1 Lonza Company Details
11.2.2 Lonza Business Overview
11.2.3 Lonza Pediatric Drug Development Services Introduction
11.2.4 Lonza Revenue in Pediatric Drug Development Services Business (2019-2024)
11.2.5 Lonza Recent Development
11.3 Fortrea
11.3.1 Fortrea Company Details
11.3.2 Fortrea Business Overview
11.3.3 Fortrea Pediatric Drug Development Services Introduction
11.3.4 Fortrea Revenue in Pediatric Drug Development Services Business (2019-2024)
11.3.5 Fortrea Recent Development
11.4 Certara
11.4.1 Certara Company Details
11.4.2 Certara Business Overview
11.4.3 Certara Pediatric Drug Development Services Introduction
11.4.4 Certara Revenue in Pediatric Drug Development Services Business (2019-2024)
11.4.5 Certara Recent Development
11.5 NGT BioPharma
11.5.1 NGT BioPharma Company Details
11.5.2 NGT BioPharma Business Overview
11.5.3 NGT BioPharma Pediatric Drug Development Services Introduction
11.5.4 NGT BioPharma Revenue in Pediatric Drug Development Services Business (2019-2024)
11.5.5 NGT BioPharma Recent Development
11.6 PCI
11.6.1 PCI Company Details
11.6.2 PCI Business Overview
11.6.3 PCI Pediatric Drug Development Services Introduction
11.6.4 PCI Revenue in Pediatric Drug Development Services Business (2019-2024)
11.6.5 PCI Recent Development
11.7 Allucent
11.7.1 Allucent Company Details
11.7.2 Allucent Business Overview
11.7.3 Allucent Pediatric Drug Development Services Introduction
11.7.4 Allucent Revenue in Pediatric Drug Development Services Business (2019-2024)
11.7.5 Allucent Recent Development
11.8 CTI
11.8.1 CTI Company Details
11.8.2 CTI Business Overview
11.8.3 CTI Pediatric Drug Development Services Introduction
11.8.4 CTI Revenue in Pediatric Drug Development Services Business (2019-2024)
11.8.5 CTI Recent Development
11.9 Sun-Novo
11.9.1 Sun-Novo Company Details
11.9.2 Sun-Novo Business Overview
11.9.3 Sun-Novo Pediatric Drug Development Services Introduction
11.9.4 Sun-Novo Revenue in Pediatric Drug Development Services Business (2019-2024)
11.9.5 Sun-Novo Recent Development
11.10 ICON
11.10.1 ICON Company Details
11.10.2 ICON Business Overview
11.10.3 ICON Pediatric Drug Development Services Introduction
11.10.4 ICON Revenue in Pediatric Drug Development Services Business (2019-2024)
11.10.5 ICON Recent Development
11.11 Lewwin Pharma
11.11.1 Lewwin Pharma Company Details
11.11.2 Lewwin Pharma Business Overview
11.11.3 Lewwin Pharma Pediatric Drug Development Services Introduction
11.11.4 Lewwin Pharma Revenue in Pediatric Drug Development Services Business (2019-2024)
11.11.5 Lewwin Pharma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Pediatric Drug Development Services Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Preclinical Services
Table 3. Key Players of Clinical Services
Table 4. Global Pediatric Drug Development Services Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Pediatric Drug Development Services Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Pediatric Drug Development Services Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Pediatric Drug Development Services Market Share by Region (2019-2024)
Table 8. Global Pediatric Drug Development Services Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Pediatric Drug Development Services Market Share by Region (2025-2030)
Table 10. Pediatric Drug Development Services Market Trends
Table 11. Pediatric Drug Development Services Market Drivers
Table 12. Pediatric Drug Development Services Market Challenges
Table 13. Pediatric Drug Development Services Market Restraints
Table 14. Global Pediatric Drug Development Services Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Pediatric Drug Development Services Market Share by Players (2019-2024)
Table 16. Global Top Pediatric Drug Development Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pediatric Drug Development Services as of 2023)
Table 17. Ranking of Global Top Pediatric Drug Development Services Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Pediatric Drug Development Services Revenue (CR5 and HHI) & (2019-2024)
Table 19. Global Key Players of Pediatric Drug Development Services, Headquarters and Area Served
Table 20. Global Key Players of Pediatric Drug Development Services, Product and Application
Table 21. Global Key Players of Pediatric Drug Development Services, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Pediatric Drug Development Services Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Pediatric Drug Development Services Revenue Market Share by Type (2019-2024)
Table 25. Global Pediatric Drug Development Services Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Pediatric Drug Development Services Revenue Market Share by Type (2025-2030)
Table 27. Global Pediatric Drug Development Services Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Pediatric Drug Development Services Revenue Market Share by Application (2019-2024)
Table 29. Global Pediatric Drug Development Services Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Pediatric Drug Development Services Revenue Market Share by Application (2025-2030)
Table 31. North America Pediatric Drug Development Services Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Pediatric Drug Development Services Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Pediatric Drug Development Services Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Pediatric Drug Development Services Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Pediatric Drug Development Services Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Pediatric Drug Development Services Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Pediatric Drug Development Services Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Pediatric Drug Development Services Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Pediatric Drug Development Services Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Pediatric Drug Development Services Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Pediatric Drug Development Services Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Pediatric Drug Development Services Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Pediatric Drug Development Services Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Pediatric Drug Development Services Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Pediatric Drug Development Services Market Size by Country (2025-2030) & (US$ Million)
Table 46. IQVIA Company Details
Table 47. IQVIA Business Overview
Table 48. IQVIA Pediatric Drug Development Services Product
Table 49. IQVIA Revenue in Pediatric Drug Development Services Business (2019-2024) & (US$ Million)
Table 50. IQVIA Recent Development
Table 51. Lonza Company Details
Table 52. Lonza Business Overview
Table 53. Lonza Pediatric Drug Development Services Product
Table 54. Lonza Revenue in Pediatric Drug Development Services Business (2019-2024) & (US$ Million)
Table 55. Lonza Recent Development
Table 56. Fortrea Company Details
Table 57. Fortrea Business Overview
Table 58. Fortrea Pediatric Drug Development Services Product
Table 59. Fortrea Revenue in Pediatric Drug Development Services Business (2019-2024) & (US$ Million)
Table 60. Fortrea Recent Development
Table 61. Certara Company Details
Table 62. Certara Business Overview
Table 63. Certara Pediatric Drug Development Services Product
Table 64. Certara Revenue in Pediatric Drug Development Services Business (2019-2024) & (US$ Million)
Table 65. Certara Recent Development
Table 66. NGT BioPharma Company Details
Table 67. NGT BioPharma Business Overview
Table 68. NGT BioPharma Pediatric Drug Development Services Product
Table 69. NGT BioPharma Revenue in Pediatric Drug Development Services Business (2019-2024) & (US$ Million)
Table 70. NGT BioPharma Recent Development
Table 71. PCI Company Details
Table 72. PCI Business Overview
Table 73. PCI Pediatric Drug Development Services Product
Table 74. PCI Revenue in Pediatric Drug Development Services Business (2019-2024) & (US$ Million)
Table 75. PCI Recent Development
Table 76. Allucent Company Details
Table 77. Allucent Business Overview
Table 78. Allucent Pediatric Drug Development Services Product
Table 79. Allucent Revenue in Pediatric Drug Development Services Business (2019-2024) & (US$ Million)
Table 80. Allucent Recent Development
Table 81. CTI Company Details
Table 82. CTI Business Overview
Table 83. CTI Pediatric Drug Development Services Product
Table 84. CTI Revenue in Pediatric Drug Development Services Business (2019-2024) & (US$ Million)
Table 85. CTI Recent Development
Table 86. Sun-Novo Company Details
Table 87. Sun-Novo Business Overview
Table 88. Sun-Novo Pediatric Drug Development Services Product
Table 89. Sun-Novo Revenue in Pediatric Drug Development Services Business (2019-2024) & (US$ Million)
Table 90. Sun-Novo Recent Development
Table 91. ICON Company Details
Table 92. ICON Business Overview
Table 93. ICON Pediatric Drug Development Services Product
Table 94. ICON Revenue in Pediatric Drug Development Services Business (2019-2024) & (US$ Million)
Table 95. ICON Recent Development
Table 96. Lewwin Pharma Company Details
Table 97. Lewwin Pharma Business Overview
Table 98. Lewwin Pharma Pediatric Drug Development Services Product
Table 99. Lewwin Pharma Revenue in Pediatric Drug Development Services Business (2019-2024) & (US$ Million)
Table 100. Lewwin Pharma Recent Development
Table 101. Research Programs/Design for This Report
Table 102. Key Data Information from Secondary Sources
Table 103. Key Data Information from Primary Sources
Table 104. Authors List of This Report
List of Figures
Figure 1. Pediatric Drug Development Services Picture
Figure 2. Global Pediatric Drug Development Services Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Pediatric Drug Development Services Market Share by Type: 2023 VS 2030
Figure 4. Preclinical Services Features
Figure 5. Clinical Services Features
Figure 6. Global Pediatric Drug Development Services Market Size by Application (2024-2030) & (US$ Million)
Figure 7. Global Pediatric Drug Development Services Market Share by Application: 2023 VS 2030
Figure 8. Pharmaceutical Companies Case Studies
Figure 9. Medical Device Companies Case Studies
Figure 10. Others Case Studies
Figure 11. Pediatric Drug Development Services Report Years Considered
Figure 12. Global Pediatric Drug Development Services Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 13. Global Pediatric Drug Development Services Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Pediatric Drug Development Services Market Share by Region: 2023 VS 2030
Figure 15. Global Pediatric Drug Development Services Market Share by Players in 2023
Figure 16. Global Top Pediatric Drug Development Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pediatric Drug Development Services as of 2023)
Figure 17. The Top 10 and 5 Players Market Share by Pediatric Drug Development Services Revenue in 2023
Figure 18. North America Pediatric Drug Development Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. North America Pediatric Drug Development Services Market Share by Country (2019-2030)
Figure 20. United States Pediatric Drug Development Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Canada Pediatric Drug Development Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Pediatric Drug Development Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Pediatric Drug Development Services Market Share by Country (2019-2030)
Figure 24. Germany Pediatric Drug Development Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. France Pediatric Drug Development Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. U.K. Pediatric Drug Development Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Italy Pediatric Drug Development Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Russia Pediatric Drug Development Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Nordic Countries Pediatric Drug Development Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Pediatric Drug Development Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Pediatric Drug Development Services Market Share by Region (2019-2030)
Figure 32. China Pediatric Drug Development Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Japan Pediatric Drug Development Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. South Korea Pediatric Drug Development Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Southeast Asia Pediatric Drug Development Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. India Pediatric Drug Development Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Australia Pediatric Drug Development Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Pediatric Drug Development Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Pediatric Drug Development Services Market Share by Country (2019-2030)
Figure 40. Mexico Pediatric Drug Development Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Brazil Pediatric Drug Development Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Pediatric Drug Development Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Pediatric Drug Development Services Market Share by Country (2019-2030)
Figure 44. Turkey Pediatric Drug Development Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Saudi Arabia Pediatric Drug Development Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. UAE Pediatric Drug Development Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. IQVIA Revenue Growth Rate in Pediatric Drug Development Services Business (2019-2024)
Figure 48. Lonza Revenue Growth Rate in Pediatric Drug Development Services Business (2019-2024)
Figure 49. Fortrea Revenue Growth Rate in Pediatric Drug Development Services Business (2019-2024)
Figure 50. Certara Revenue Growth Rate in Pediatric Drug Development Services Business (2019-2024)
Figure 51. NGT BioPharma Revenue Growth Rate in Pediatric Drug Development Services Business (2019-2024)
Figure 52. PCI Revenue Growth Rate in Pediatric Drug Development Services Business (2019-2024)
Figure 53. Allucent Revenue Growth Rate in Pediatric Drug Development Services Business (2019-2024)
Figure 54. CTI Revenue Growth Rate in Pediatric Drug Development Services Business (2019-2024)
Figure 55. Sun-Novo Revenue Growth Rate in Pediatric Drug Development Services Business (2019-2024)
Figure 56. ICON Revenue Growth Rate in Pediatric Drug Development Services Business (2019-2024)
Figure 57. Lewwin Pharma Revenue Growth Rate in Pediatric Drug Development Services Business (2019-2024)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed
Table 1. Global Pediatric Drug Development Services Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Preclinical Services
Table 3. Key Players of Clinical Services
Table 4. Global Pediatric Drug Development Services Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Pediatric Drug Development Services Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Pediatric Drug Development Services Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Pediatric Drug Development Services Market Share by Region (2019-2024)
Table 8. Global Pediatric Drug Development Services Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Pediatric Drug Development Services Market Share by Region (2025-2030)
Table 10. Pediatric Drug Development Services Market Trends
Table 11. Pediatric Drug Development Services Market Drivers
Table 12. Pediatric Drug Development Services Market Challenges
Table 13. Pediatric Drug Development Services Market Restraints
Table 14. Global Pediatric Drug Development Services Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Pediatric Drug Development Services Market Share by Players (2019-2024)
Table 16. Global Top Pediatric Drug Development Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pediatric Drug Development Services as of 2023)
Table 17. Ranking of Global Top Pediatric Drug Development Services Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Pediatric Drug Development Services Revenue (CR5 and HHI) & (2019-2024)
Table 19. Global Key Players of Pediatric Drug Development Services, Headquarters and Area Served
Table 20. Global Key Players of Pediatric Drug Development Services, Product and Application
Table 21. Global Key Players of Pediatric Drug Development Services, Date of Enter into This Industry
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Pediatric Drug Development Services Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Pediatric Drug Development Services Revenue Market Share by Type (2019-2024)
Table 25. Global Pediatric Drug Development Services Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Pediatric Drug Development Services Revenue Market Share by Type (2025-2030)
Table 27. Global Pediatric Drug Development Services Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Pediatric Drug Development Services Revenue Market Share by Application (2019-2024)
Table 29. Global Pediatric Drug Development Services Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Pediatric Drug Development Services Revenue Market Share by Application (2025-2030)
Table 31. North America Pediatric Drug Development Services Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Pediatric Drug Development Services Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Pediatric Drug Development Services Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Pediatric Drug Development Services Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Pediatric Drug Development Services Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Pediatric Drug Development Services Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Pediatric Drug Development Services Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Pediatric Drug Development Services Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Pediatric Drug Development Services Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Pediatric Drug Development Services Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Pediatric Drug Development Services Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Pediatric Drug Development Services Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Pediatric Drug Development Services Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Pediatric Drug Development Services Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Pediatric Drug Development Services Market Size by Country (2025-2030) & (US$ Million)
Table 46. IQVIA Company Details
Table 47. IQVIA Business Overview
Table 48. IQVIA Pediatric Drug Development Services Product
Table 49. IQVIA Revenue in Pediatric Drug Development Services Business (2019-2024) & (US$ Million)
Table 50. IQVIA Recent Development
Table 51. Lonza Company Details
Table 52. Lonza Business Overview
Table 53. Lonza Pediatric Drug Development Services Product
Table 54. Lonza Revenue in Pediatric Drug Development Services Business (2019-2024) & (US$ Million)
Table 55. Lonza Recent Development
Table 56. Fortrea Company Details
Table 57. Fortrea Business Overview
Table 58. Fortrea Pediatric Drug Development Services Product
Table 59. Fortrea Revenue in Pediatric Drug Development Services Business (2019-2024) & (US$ Million)
Table 60. Fortrea Recent Development
Table 61. Certara Company Details
Table 62. Certara Business Overview
Table 63. Certara Pediatric Drug Development Services Product
Table 64. Certara Revenue in Pediatric Drug Development Services Business (2019-2024) & (US$ Million)
Table 65. Certara Recent Development
Table 66. NGT BioPharma Company Details
Table 67. NGT BioPharma Business Overview
Table 68. NGT BioPharma Pediatric Drug Development Services Product
Table 69. NGT BioPharma Revenue in Pediatric Drug Development Services Business (2019-2024) & (US$ Million)
Table 70. NGT BioPharma Recent Development
Table 71. PCI Company Details
Table 72. PCI Business Overview
Table 73. PCI Pediatric Drug Development Services Product
Table 74. PCI Revenue in Pediatric Drug Development Services Business (2019-2024) & (US$ Million)
Table 75. PCI Recent Development
Table 76. Allucent Company Details
Table 77. Allucent Business Overview
Table 78. Allucent Pediatric Drug Development Services Product
Table 79. Allucent Revenue in Pediatric Drug Development Services Business (2019-2024) & (US$ Million)
Table 80. Allucent Recent Development
Table 81. CTI Company Details
Table 82. CTI Business Overview
Table 83. CTI Pediatric Drug Development Services Product
Table 84. CTI Revenue in Pediatric Drug Development Services Business (2019-2024) & (US$ Million)
Table 85. CTI Recent Development
Table 86. Sun-Novo Company Details
Table 87. Sun-Novo Business Overview
Table 88. Sun-Novo Pediatric Drug Development Services Product
Table 89. Sun-Novo Revenue in Pediatric Drug Development Services Business (2019-2024) & (US$ Million)
Table 90. Sun-Novo Recent Development
Table 91. ICON Company Details
Table 92. ICON Business Overview
Table 93. ICON Pediatric Drug Development Services Product
Table 94. ICON Revenue in Pediatric Drug Development Services Business (2019-2024) & (US$ Million)
Table 95. ICON Recent Development
Table 96. Lewwin Pharma Company Details
Table 97. Lewwin Pharma Business Overview
Table 98. Lewwin Pharma Pediatric Drug Development Services Product
Table 99. Lewwin Pharma Revenue in Pediatric Drug Development Services Business (2019-2024) & (US$ Million)
Table 100. Lewwin Pharma Recent Development
Table 101. Research Programs/Design for This Report
Table 102. Key Data Information from Secondary Sources
Table 103. Key Data Information from Primary Sources
Table 104. Authors List of This Report
List of Figures
Figure 1. Pediatric Drug Development Services Picture
Figure 2. Global Pediatric Drug Development Services Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Pediatric Drug Development Services Market Share by Type: 2023 VS 2030
Figure 4. Preclinical Services Features
Figure 5. Clinical Services Features
Figure 6. Global Pediatric Drug Development Services Market Size by Application (2024-2030) & (US$ Million)
Figure 7. Global Pediatric Drug Development Services Market Share by Application: 2023 VS 2030
Figure 8. Pharmaceutical Companies Case Studies
Figure 9. Medical Device Companies Case Studies
Figure 10. Others Case Studies
Figure 11. Pediatric Drug Development Services Report Years Considered
Figure 12. Global Pediatric Drug Development Services Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 13. Global Pediatric Drug Development Services Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Pediatric Drug Development Services Market Share by Region: 2023 VS 2030
Figure 15. Global Pediatric Drug Development Services Market Share by Players in 2023
Figure 16. Global Top Pediatric Drug Development Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pediatric Drug Development Services as of 2023)
Figure 17. The Top 10 and 5 Players Market Share by Pediatric Drug Development Services Revenue in 2023
Figure 18. North America Pediatric Drug Development Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. North America Pediatric Drug Development Services Market Share by Country (2019-2030)
Figure 20. United States Pediatric Drug Development Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Canada Pediatric Drug Development Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Pediatric Drug Development Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Pediatric Drug Development Services Market Share by Country (2019-2030)
Figure 24. Germany Pediatric Drug Development Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. France Pediatric Drug Development Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. U.K. Pediatric Drug Development Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Italy Pediatric Drug Development Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Russia Pediatric Drug Development Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Nordic Countries Pediatric Drug Development Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Pediatric Drug Development Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Pediatric Drug Development Services Market Share by Region (2019-2030)
Figure 32. China Pediatric Drug Development Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Japan Pediatric Drug Development Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. South Korea Pediatric Drug Development Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Southeast Asia Pediatric Drug Development Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. India Pediatric Drug Development Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Australia Pediatric Drug Development Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Pediatric Drug Development Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Pediatric Drug Development Services Market Share by Country (2019-2030)
Figure 40. Mexico Pediatric Drug Development Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Brazil Pediatric Drug Development Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Pediatric Drug Development Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Pediatric Drug Development Services Market Share by Country (2019-2030)
Figure 44. Turkey Pediatric Drug Development Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Saudi Arabia Pediatric Drug Development Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. UAE Pediatric Drug Development Services Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. IQVIA Revenue Growth Rate in Pediatric Drug Development Services Business (2019-2024)
Figure 48. Lonza Revenue Growth Rate in Pediatric Drug Development Services Business (2019-2024)
Figure 49. Fortrea Revenue Growth Rate in Pediatric Drug Development Services Business (2019-2024)
Figure 50. Certara Revenue Growth Rate in Pediatric Drug Development Services Business (2019-2024)
Figure 51. NGT BioPharma Revenue Growth Rate in Pediatric Drug Development Services Business (2019-2024)
Figure 52. PCI Revenue Growth Rate in Pediatric Drug Development Services Business (2019-2024)
Figure 53. Allucent Revenue Growth Rate in Pediatric Drug Development Services Business (2019-2024)
Figure 54. CTI Revenue Growth Rate in Pediatric Drug Development Services Business (2019-2024)
Figure 55. Sun-Novo Revenue Growth Rate in Pediatric Drug Development Services Business (2019-2024)
Figure 56. ICON Revenue Growth Rate in Pediatric Drug Development Services Business (2019-2024)
Figure 57. Lewwin Pharma Revenue Growth Rate in Pediatric Drug Development Services Business (2019-2024)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Multi-Channel Temperature Controllers Market Research Report 2025
Mar 14, 25
Global Waterproof Action Cameras Market Research Report 2025
Mar 14, 25
Global Infrared IP Cameras Market Research Report 2025
Mar 14, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232